The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Updated safety and efficacy results from a phase I/II study of the oral BRAF inhibitor dabrafenib (GSK2118436) combined with the oral MEK 1/2 inhibitor trametinib (GSK1120212) in patients with BRAFi-naive metastatic melanoma.
Jeffrey S. Weber
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Keith T. Flaherty
Consultant or Advisory Role - GlaxoSmithKline
Jeffrey R. Infante
No relevant relationships to disclose
Gerald Steven Falchook
Research Funding - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline
Richard Kefford
Consultant or Advisory Role - GlaxoSmithKline
Adil Daud
No relevant relationships to disclose
Omid Hamid
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Rene Gonzalez
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Ragini Reiney Kudchadkar
No relevant relationships to disclose
Donald P. Lawrence
No relevant relationships to disclose
Howard A. Burris
No relevant relationships to disclose
Georgina V. Long
Consultant or Advisory Role - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline
Alain Patrick Algazi
Research Funding - GlaxoSmithKline
Karl D Lewis
Research Funding - GlaxoSmithKline
Kevin B. Kim
Research Funding - GlaxoSmithKline
Igor Puzanov
Consultant or Advisory Role - GlaxoSmithKline
Peng Sun
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Shonda M Little
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Kiran Patel
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Jeffrey Alan Sosman
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline